journal article·2024

Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma

Mohammad Habeeb, Hariharan Thirumalai Vengateswaran, Huay Woon You, Kundharu Saddhono, Kiran Balasaheb Aher, Girija Balasaheb Bhavar

Journal of Materials Chemistry B· Volume 12· Issue 7
Publisher page

Abstract

Glioblastoma (GBM) is a highly aggressive and lethal type of brain tumor with complex and diverse molecular signaling pathways involved that are in its development and progression. Despite numerous attempts to develop effective treatments, the survival rate remains low. Therefore, understanding the molecular mechanisms of these pathways can aid in the development of targeted therapies for the treatment of glioblastoma. Nanomedicines have shown potential in targeting and blocking signaling pathways involved in glioblastoma. Nanomedicines can be engineered to specifically target tumor sites, bypass the blood-brain barrier (BBB), and release drugs over an extended period. However, current nanomedicine strategies also face limitations, including poor stability, toxicity, and low therapeutic efficacy. Therefore, novel and advanced nanomedicine-based strategies must be developed for enhanced drug delivery. In this review, we highlight risk factors and chemotherapeutics for the treatment of glioblastoma. Further, we discuss different nanoformulations fabricated using synthetic and natural materials for treatment and diagnosis to selectively target signaling pathways involved in GBM. Furthermore, we discuss current clinical strategies and the role of artificial intelligence in the field of nanomedicine for targeting GBM.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Cancer, Stress, Anesthesia, and Immune Response

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics, Crescent School of Pharmacy, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai-600048, India

Pusat PERMATA@Pintar Negara, Universiti Kebangsaan 43600, Bangi, Selangor, Malaysia

Faculty of Teacher Training and Education, Universitas Sebelas Maret, 57126, Indonesia

Department of Pharmaceutical Quality Assurance, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra, 424001, India

Department of Pharmaceutical Chemistry, Shri Vile Parle Kelavani Mandal's Institute of Pharmacy, Dhule, Maharashtra, 424001, India

References (100+)

Show source-provided references
1. Pucci · Acta Biomater. · 2022 · 139 · 21810.1016/j.actbio.2021.04.005 ↗
2. Global Cancer Observatory, https://gco.iarc.fr/ , accessed 28 December 2023
3. World Health Organization (WHO), https://www.who.int/ , accessed 28 December 2023
4. El Moukhtari · J. Controlled Release · 2022 · 348 · 55310.1016/j.jconrel.2022.06.010 ↗
5. Noorani · Nat. Commun. · 2023 · 14 · 110.1038/s41467-022-35709-0 ↗
6. Martins · J. Controlled Release · 2023 · 353 · 7710.1016/j.jconrel.2022.11.024 ↗
7. Habeeb · J. Drug Delivery Sci. Technol. · 2022 · 77 · 10386510.1016/j.jddst.2022.103865 ↗
8. Baladi · Arabian J. Chem. · 2023 · 16 · 10484110.1016/j.arabjc.2023.104841 ↗
9. Griveau · Int. J. Pharm.: X · 2022 · 4 · 10012910.1016/j.ijpx.2022.100129 ↗
10. Janjua · J. Controlled Release · 2023 · 357 · 16110.1016/j.jconrel.2023.03.040 ↗
11. Habeeb · Biointerface Res. Appl. Chem. · 2022 · 12 · 518710.33263/BRIAC124.51875198 ↗
12. Martínez-Garcia · Clin. Transl. Oncol. · 2018 · 20 · 2210.1007/s12094-017-1763-6 ↗
13. Jiang · Cancer Lett. · 2021 · 499 · 6010.1016/j.canlet.2020.10.050 ↗
14. Weller · Nat. Rev. Clin. Oncol. · 2021 · 18 · 17010.1038/s41571-020-00447-z ↗
15. Hayes · Pract. Radiat. Oncol. · 2018 · 4 · 23010.1016/j.prro.2018.01.006 ↗
16. Stupp · Ann. Oncol. · 2014 · 25 · 9310.1093/annonc/mdu050 ↗
17. World Health Organization (WHO), https://www.who.int/ , accessed 6 October 2023
18. Chen · Magn. Reson. Imaging · 2023 · 102 · 9610.3748/wjg.v29.i28.4384 ↗
19. Sae-Huang · Brain Spine · 2022 · 2 · 10169210.1016/j.bas.2022.101692 ↗
20. Hansen · Interdiscip. Neurosurg. · 2023 · 11 · 120854710.1016/j.inat.2023.101756 ↗
21. Mellinger · Int. J. Pharm. · 2023 · 12342110.1016/j.ijpharm.2023.123421 ↗
22. Cao · Heliyon · 2023 · 7 · e1831010.1016/j.heliyon.2023.e18310 ↗
23. Natukka · World Neurosurg. · 2023 · 177 · e78510.1016/j.wneu.2023.07.008 ↗
24. Zhao · Clin Neurol. Neurosurg. · 2022 · 221 · 10739110.1016/j.clineuro.2022.107391 ↗
25. Rydelius · Magn. Reson. Imaging · 2023 · 104 · 8810.1016/j.mri.2023.09.005 ↗
26. Kapteijn · Thromb. Res. · 2023 · 221 · 1010.1016/j.thromres.2022.11.013 ↗
27. Fu · Interdiscip. Neurosurg. · 2023 · 32 · 10173610.1016/j.inat.2023.101736 ↗
28. Ranjan · Cell Rep. Med. · 2023 · 4 · 10102510.1016/j.xcrm.2023.101025 ↗
29. Le Rhun · Eur. J. Cancer · 2023 · 178 · 1310.1093/neuonc/noad038 ↗
30. Xie · Dev. Cell · 2022 · 57 · 3210.1016/j.devcel.2021.12.007 ↗
31. Pucci · Acta Biomater. · 2022 · 139 · 21810.1016/j.actbio.2021.04.005 ↗
32. Wei · Heliyon · 2023 · 1 · e1282010.1016/j.heliyon.2023.e12820 ↗
33. Aldoghachi · Neuroscience · 2022 · 491 · 24010.1016/j.neuroscience.2022.03.030 ↗
34. Udoikono · J. Photochem. Photobiol. · 2022 · 10 · 10011610.1016/j.jpap.2022.100116 ↗
35. Werner · Photodiagn. Photodyn. Ther. · 2022 · 39 · 10298710.1016/j.pdpdt.2022.102987 ↗
36. Liang · Biochem. Biophys. Rep. · 2022 · 32 · 10134210.1016/j.bbrep.2022.101342 ↗
37. Natukka · World Neurosurg. · 2023 · 177 · e78510.1016/j.wneu.2023.07.008 ↗
38. Khan · Heliyon · 2023 · 7 · e1760110.1016/j.heliyon.2023.e17601 ↗
39. Fisher · Biomedicines · 2021 · 9 · 32410.3390/biomedicines9030324 ↗
40. Wu · Pharmacol. Res. · 2021 · 171 · 10578010.1016/j.phrs.2021.105780 ↗
41. Ahmad · Int. J. Biol. Macromol. · 2022 · 221 · 43510.1016/j.ijbiomac.2022.08.210 ↗
42. Rudnick · J. Clin. Neurosci. · 2020 · 74 · 18710.1016/j.jocn.2020.03.006 ↗
43. Reijneveld · Eur. J. Cancer · 2023 · 11294610.1016/j.ejca.2023.112946 ↗
44. Skaga · Transl. Oncol. · 2022 · 26 · 10153510.1016/j.tranon.2022.101535 ↗
45. Tsaur · Cancer Lett. · 2011 · 313 · 8410.3390/cancers11060777 ↗
46. Zettler · EJC Paediatr. Oncol. · 2023 · 1 · 10000510.1016/j.ejcped.2023.100005 ↗
47. A.Dasgupta , S.Ghosh , K.Kalidass and S.Farisha , Computational Methods in Drug Discovery and Repurposing for Cancer Therapy , 2023 , pp. 147–20010.1016/B978-0-443-15280-1.00013-3 ↗
48. Priyarega · Results Chem. · 2022 · 4 · 10035610.1016/j.rechem.2022.100356 ↗
49. Cao · Heliyon · 2023 · 7 · e1831010.1016/j.heliyon.2023.e18310 ↗
50. Natukka · World Neurosurg. · 2023 · 177 · e78510.1016/j.wneu.2023.07.008 ↗
51. Wu · Brain Behav. Immun. · 2020 · 89 · 24510.1016/j.bbi.2020.06.028 ↗
52. You · Displays · 2023 · 77 · 10239910.1016/j.displa.2023.102399 ↗
53. Hashemi · Biomed. Pharmacother. · 2023 · 158 · 11420410.15252/embj.2021109187 ↗
54. Zou · Int. J. Biol. Macromol. · 2022 · 202 · 53910.1016/j.ijbiomac.2022.01.113 ↗
55. Vazirian · Food Chem. Toxicol. · 2018 · 122 · 6910.1016/j.fct.2018.09.079 ↗
56. Kabir · Arabian J. Chem. · 2022 · 15 · 10401310.1016/j.arabjc.2022.104013 ↗
57. Kasenda · ESMO Open · 2022 · 1 · 10036510.1016/j.esmoop.2021.100365 ↗
58. M.Wu , P. Z.-C. letters and undefined, 2020 , Elsevier
59. Noeuveglise · ESMO Open · 2023 · 1 · 10074010.1016/j.esmoop.2022.100740 ↗
60. Huang · Nanomedicine · 2022 · 40 · 10250910.1016/j.nano.2021.102509 ↗
61. Levantini · Semin. Cancer Biol. · 2022 · 85 · 25310.1016/j.semcancer.2022.04.002 ↗
62. Hamidian · Results Chem. · 2023 · 5 · 10073410.1016/j.rechem.2022.100734 ↗
63. Alnemeh-Al Ali · Int. J. Pharm.: X · 2022 · 4 · 10012810.1016/j.ijpx.2022.100128 ↗
64. M.Hashemi and S.Hasani , … S. H.-I. J. of and undefined, 2022 , Elsevier
65. Aggarwal · Biomolecules · 2019 · 11 · 73510.3390/biom9110735 ↗
66. Farooqi · Pharmacol. Res. · 2020 · 160 · 10518810.1016/j.phrs.2020.105188 ↗
67. Wesley · Brain Res. · 2022 · 1776 · 14775210.1016/j.brainres.2021.147752 ↗
68. Vimalraj · Int. J. Biol. Macromol. · 2022 · 221 · 142810.1016/j.ijbiomac.2022.09.129 ↗
69. Ghalehbandi · Eur. J. Pharmacol. · 2023 · 949 · 17558610.1016/j.ejphar.2023.175586 ↗
70. Papadopoulos · Mol. Aspects Med. · 2018 · 62 · 7510.1016/j.mam.2017.11.007 ↗
71. Sil · Mol. Aspects Med. · 2018 · 62 · 6310.1016/j.mam.2018.01.006 ↗
72. Mejía-Rodríguez · Biochem. Biophys. Rep. · 2023 · 33 · 10143010.1016/j.bbrep.2023.101430 ↗
73. Ye · Nat. Metab. · 2019 · 4 · 43110.1038/s42255-019-0045-8 ↗
74. Alafandi · Eur. J. Cancer · 2023 · 188 · 12210.1016/j.ejca.2023.04.021 ↗
75. Singh · Carbohydr. Polym. · 2018 · 180 · 36510.1016/j.carbpol.2017.10.030 ↗
76. Song · Biomacromolecules · 2021 · 22 · 292110.1021/acs.biomac.1c00314 ↗
77. Sathiyaseelan · Int. J. Biol. Macromol. · 2020 · 163 · 3610.1016/j.ijbiomac.2020.06.165 ↗
78. Kesavan · J. Drug Delivery Sci. Technol. · 2023 · 4 · 196310.1016/j.jddst.2021.102760 ↗
79. Battogtokh · Nanomedicine · 2019 · 18 · 31510.1016/j.nano.2018.10.007 ↗
80. Li · Int. J. Biol. Macromol. · 2018 · 107 · 20410.1016/j.ijbiomac.2017.08.155 ↗
81. Ramalho · Int. J. Pharm. · 2018 · 545 · 8410.1016/j.ijpharm.2018.04.062 ↗
82. Bhattacharya · J. Exp. Nanosci. · 2021 · 16 · 34510.1080/17458080.2021.1983172 ↗
83. Maliyakkal · Saudi Pharm. J. · 2021 · 29 · 85710.1016/j.jsps.2021.07.001 ↗
84. Senturk · Colloids Surf., A · 2023 · 10 · 10222910.1016/j.colsurfa.2021.126648 ↗
85. Pucci · Acta Biomater. · 2022 · 139 · 21810.1016/j.actbio.2021.04.005 ↗
86. Wang · Biomed. Pharmacother. · 2021 · 138 · 11146110.1016/j.biopha.2021.111461 ↗
87. Zwain · Mater. Sci. Eng., C · 2021 · 21 · 11177410.1016/j.msec.2020.111774 ↗
88. Ak · Colloids Surf., B · 2021 · 206 · 11194610.1016/j.colsurfb.2021.111946 ↗
89. Alves · J. Inorg. Biochem. · 2020 · 205 · 11098410.1016/j.jinorgbio.2019.110984 ↗
90. Lakkadwala · Colloids Surf., B · 2019 · 173 · 2710.1016/j.colsurfb.2018.09.047 ↗
91. Papachristodoulou · J. Controlled Release · 2019 · 295 · 13010.1016/j.jconrel.2018.12.009 ↗
92. Ashrafzadeh · Int. J. Nanomed. · 2020 · 15 · 703510.2147/IJN.S255902 ↗
93. Lam · Nat. Commun. · 2018 · 9 · 199110.1038/s41467-018-04315-4 ↗
94. Yao · Nanomedicine · 2022 · 43 · 10255410.1016/j.nano.2022.102554 ↗
95. S.Sahab-Negah , F.Ariakia , M.Jalili-Nik , A. R.Afshari , S.Salehi , F.Samini , G.Rajabzadeh , A.Gorji and G.Rajabzadeh GhRajabzadeh 10.1007/s12035-020-01922-5/Published10.1007/s12035-020-01922-5/Published ↗
96. De · Nanobiomedicine · 2018 · 5 · 110.1186/s12943-022-01708-4 ↗
97. Attia · J. Drug Delivery Sci. Technol. · 2019 · 53 · 10121910.1016/j.jddst.2019.101219 ↗
98. Seleci · Int. J. Mol. Sci. · 2019 · 19 · 469610.3390/ijms20194696 ↗
99. Gharbavi · ACS Chem. Neurosci. · 2020 · 11 · 449910.1021/acschemneuro.0c00699 ↗
100. Abdalla · J. Nanobiotechnol. · 2021 · 19 · 6010.1186/s12951-021-00798-4 ↗